The present invention relates to the CGRP antagonists of general formula
wherein A, X and R
1
to R
3
are defined as in claim 1, the tautomers, the diastereomers, the enantiomers, the hydrates thereof, the mixtures thereof and the salts thereof and the hydrates of the salts, particularly the physiologically acceptable salts thereof with inorganic or organic acids, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof.
本发明涉及一般式中的CGRP拮抗剂,其中A、X和R1至R3如权利要求书中所定义,其互变异构体、对映异构体、立体异构体、
水合物、混合物及其盐以及盐的
水合物,特别是与无机或有机酸形成的生理上可接受的盐,含有这些化合物的药物组合物,其使用以及其制备方法。